Predictors and time-related impact of distal embolization during primary angioplasty

European Heart Journal

Volumn 30, Issue 3, 2009, Pages 305-313

  Napodano, Massimo ^a   Ramondo, Angelo ^a   Tarantini, Giuseppe ^a   Peluso, Diletta ^a   Compagno, Silvia ^a   Fraccaro, Chiara ^a   Frigo, Anna Chiara ^a   Razzolini, Renato ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Distal embolization; Myocardial infarction; Myocardial reperfusion; Primary angioplasty; Thrombus

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; TROPONIN I;

ADULT; ANGIOPLASTY; ARTERY DIAMETER; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DISTAL EMBOLIZATION; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGHT CORONARY ARTERY; SCORING SYSTEM; ST SEGMENT ELEVATION; SYMPTOM; THROMBUS; TIME; TREATMENT DURATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NECROSIS; PROSPECTIVE STUDIES; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 59749105952     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn594     Document Type: Article

References (29)

1. Antman MA, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 2004;44:671-719.
2. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty, with or without abciximab, in acute myocardial infarction. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. N Engl J Med 2002;346:957- 966.
3. Henriques JPS, Zijlstra F, Ottervanger JP, de Boer M-J, van't Hof AWJ, Hoorntje JCA, Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-1117.
4. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KKL, Kuntz RE. Randomized trial of a distal protection device during percutaneous intervention of saphenous vein aorto-coronary by-pass graft. Circulation 2002;105:1285-1290.
5. Napodano M, Pasquetto G, Saccà S, Cernetti C, Scarabeo V, Pascotto P, Reimers B. Intracoronary thrombectomy improves myocardial reperfusion during direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003;42:1395-1402.
6. Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J, for the AIMI Investigators. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006;48:244-252.
7. Kaltoft A, Bøttcher M, Nielsen SS, Hansen HHT, Terkelsen C, Mæng M, Kristensen J, Thuesen L, Krusell LR, Kristensen SD, Andersen HR, Lassen JF, Rasmussen K, Rehling M, Nielsen TT, Bøtker HE. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 2006;114:40-47.
8. Stone GW, Webb JG, Cox DA, Brodie BR, Qureshi M, Kalynich A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293:1063- 1072.
9. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, Comberg T, Peitz K, Zohlnhöfer D, Bassignana V, Buettner HJ, Neumann FJ. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-1469.
10. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2002;282:H766-H772.
11. Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Perazzolo Marra M, Bacchiega E, Napodano M, Bilato C, Razzolini R, Iliceto S. Duration of ischemia is a major determinant of transmurality and microvacular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005;46:1229-1235.
12. Broll S, Glaser S. Calculating sample size bounds for logistic regression. Prev Vet Med 2002;54:105-111.
13. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
14. van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade. Circulation 1998;97:2302-2306.
15. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 2002;122:1322-1332.
16. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001;103:2550-2554.
17. van't Hof AWJ, Leim A, de Boer MJ, Zijlstra F. Clinical value of 12-leads electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615-619.
18. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendation for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
19. Henriques JPS, Zijlstra F, van't Hof AWJ, de Boer MJ, Dambrink JHE, Gosselink M, Hoorntje JCA, Suryapranata H. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003;107:2115-2119.
20. Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004;44:305-312.
21. Mizote I, Ueda Y, Ohtani T, Shimizu M, Takeda Y, Oka T, Tsujimoto M, Hirayama A, Hori M, Kodama K. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation 2005;112:1001-1007.
22. Mehran R, Dangas G, Mintz G, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 2000;101:604-610.
23. Sakuma T, Leong-Poi H, Fisher NG, Goodman NC, Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr 2003;16:15-21.
24. Reffelmann T, Kloner RA. The 'no-reflow' phenomenon: basic science and clinical correlates. Heart 2002;87:162-168.
25. De Luca G, Suryapranata H, Zijlstra F, van't Hof AWJ, Hoorntje JCA, Gosselink ATM, Dambrink JH, de Boer MJ. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-997.
26. Tarantini G, Razzolini R, Cacciavillani L, Bilato C, Sarais C, Corbetti F, Perazzolo Marra M, Napodano M, Ramondo A, Iliceto S. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol 2006;98:1033-1040.
27. Kim RJ, Shah DJ. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is 'alive' is not enough. Heart 2004;90:137-140.
28. Biagini E, Galema TW, Schinkel AF, Vletter WB, Roelandt JR, Ten Cate FJ. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2004;43:1489-1493.
29. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellmann P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253- 2259.